The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4-(4-(Cyclopropylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-2-fluoro-5-methoxyphenyl)(morpholino)methanone ID: ALA2178135
PubChem CID: 71451847
Max Phase: Preclinical
Molecular Formula: C20H21F4N5O3
Molecular Weight: 455.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(C(=O)N2CCOCC2)c(F)cc1Nc1ncc(C(F)(F)F)c(NC2CC2)n1
Standard InChI: InChI=1S/C20H21F4N5O3/c1-31-16-8-12(18(30)29-4-6-32-7-5-29)14(21)9-15(16)27-19-25-10-13(20(22,23)24)17(28-19)26-11-2-3-11/h8-11H,2-7H2,1H3,(H2,25,26,27,28)
Standard InChI Key: FKNAWDCGDQUZRV-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
24.4621 -31.4660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7481 -31.8705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0464 -30.6447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7522 -30.2361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4607 -28.1931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4595 -29.0126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1676 -29.4216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8772 -29.0121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8744 -28.1895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1658 -27.7842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1674 -30.2388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4596 -30.6472 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8750 -30.6475 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.0430 -31.4625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.1633 -26.9670 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8698 -26.5563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5766 -26.9652 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2826 -26.5551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2806 -25.7371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5667 -25.3308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8637 -25.7431 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.9914 -26.9620 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.9866 -25.3254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6960 -25.7310 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.9831 -24.5082 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
28.6884 -24.9120 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.9934 -27.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7529 -27.7846 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.7527 -26.9674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5856 -29.4196 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
27.5908 -28.4870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4079 -28.4850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
7 11 1 0
11 12 1 0
11 13 2 0
12 4 1 0
12 1 1 0
4 3 1 0
3 14 1 0
14 2 1 0
2 1 1 0
10 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
18 22 1 0
19 23 1 0
23 24 1 0
23 25 1 0
23 26 1 0
22 27 1 0
5 28 1 0
28 29 1 0
8 30 1 0
31 27 1 0
32 31 1 0
27 32 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 455.41Molecular Weight (Monoisotopic): 455.1581AlogP: 3.43#Rotatable Bonds: 6Polar Surface Area: 88.61Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.38CX Basic pKa: 3.38CX LogP: 2.64CX LogD: 2.64Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.65Np Likeness Score: -1.74
References 1. Estrada AA, Liu X, Baker-Glenn C, Beresford A, Burdick DJ, Chambers M, Chan BK, Chen H, Ding X, DiPasquale AG, Dominguez SL, Dotson J, Drummond J, Flagella M, Flynn S, Fuji R, Gill A, Gunzner-Toste J, Harris SF, Heffron TP, Kleinheinz T, Lee DW, Le Pichon CE, Lyssikatos JP, Medhurst AD, Moffat JG, Mukund S, Nash K, Scearce-Levie K, Sheng Z, Shore DG, Tran T, Trivedi N, Wang S, Zhang S, Zhang X, Zhao G, Zhu H, Sweeney ZK.. (2012) Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors., 55 (22): [PMID:22985112 ] [10.1021/jm301020q ]